Sildenafil Tablet
Product Images NDC 65162-351

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 65162-351). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafil Tablets 20mg 1

A line chart showing estimated cumulative mortality rate (%) over time in years for three groups labeled High Dose, Medium Dose, and Low Dose. The chart includes a number at risk table above the x-axis corresponding to each dose group over the 5-year period, indicating sample size decline over time.*

FDA Label Image

Sildenafil Tablets 20mg 10

Sildenafil Tablets, USP 20 mg oral tablets label from Amneal Pharmaceuticals LLC. The label indicates 1,000 tablets per package with a prescription-only designation. Storage instructions specify controlled room temperature. Manufacturing is credited to Amneal Pharmaceuticals Pvt. Ltd. in India, with distribution by Amneal Pharmaceuticals LLC, Bridgewater, NJ. The label includes the product NDC 65162-351-11 and barcode.*

FDA Label Image

Sildenafil Tablets 20mg 2

Chemical structure of Sildenafil, showing its molecular arrangement including functional groups such as sulfonyl, methyl, and carboxyl groups in a complex ring system.*

FDA Label Image

Sildenafil Tablets 20mg 3

A chart showing fold change and 90% confidence intervals in drug interaction effects of various interacting drugs on Sildenafil's AUC and Cmax. The graph indicates recommendations such as no dose adjustment for most drugs and cautions like coadministration not recommended for Ritonavir. The vertical solid line at x=1 represents no change relative to Sildenafil alone.*

FDA Label Image

Sildenafil Tablets 20mg 4

A chart illustrating fold change and 90% confidence intervals for various drugs when interacting with sildenafil, showing changes relative to the interacting drug alone. The chart includes drugs such as Acenocoumarol, Aspirin, Atorvastatin, Bosentan, and others, with corresponding recommendations on dose adjustments.*

FDA Label Image

Sildenafil Tablets 20mg 5

A line plot showing changes from baseline in a measured variable (in centimeters) across three time points: Week 4, Week 6, and Week 12. The plot compares four groups labeled as Sildenafil 40mg TID, Placebo, Sildenafil 60mg TID, and Sildenafil 20mg TID, with error bars indicating variability at each time point.*

FDA Label Image

Sildenafil Tablets 20mg 6

A forest plot chart depicting placebo-corrected change in 6-minute walk distance (meters) for Sildenafil 20 mg taken three times daily (TID) across various patient subgroups. Subgroups displayed include baseline walk distance, etiology of pulmonary arterial hypertension (PAH), functional capacity class, gender, age, mean pulmonary arterial pressure (PAP), and pulmonary vascular resistance index (PVRI). The chart compares placebo and Sildenafil groups in each subgroup with confidence intervals shown.*

FDA Label Image

Sildenafil Tablets 20mg 7

A line graph depicting the percentage of subjects without a clinically worsening event over a 112-day period from randomization. Two curves are shown: one for Sildenafil and one for Placebo, with Sildenafil maintaining a higher percentage throughout the duration. The x-axis represents days from randomization, and the y-axis represents the percentage without clinical worsening.*

FDA Label Image

Sildenafil Tablets 20mg 8

A line graph showing the mean change from baseline in meters (with standard error) across three treatment groups (Sildenafil 1 mg TID, Sildenafil 5 mg TID, Sildenafil 20 mg TID) over 12 weeks of study. The x-axis represents weeks 4, 8, and 12, while the y-axis shows change from baseline in meters.*

FDA Label Image

Sildenafil Tablets 20mg 9

Sildenafil Tablets USP 20 mg film-coated tablets packaging label from Amneal Pharmaceuticals LLC. The label includes the NDC number 65162-351 and indicates 90 tablets per container. It shows storage instructions and manufacturing information by Amneal Pharmaceuticals Pvt. Ltd., India, with distribution by Amneal Pharmaceuticals LLC, Bridgewater, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.